Towards a Framework for Alignment Between Automotive Safety and Security Standards

Modern automotive systems increasingly rely on software and network connectivity for new functions and features. Security of the software and communications of the on-board system of systems becomes a critical concern for the safety of new generation vehicles. Besides methods and tools, safety and security of automotive systems requires frameworks of standards for holistic process and assurance. As a part of our ongoing work, this paper investigates the possibility of a combined safety and security approach to standards in the automotive domain. We examine existing approaches in the railway and avionics domain with similar challenges and identify speci c requirements for the automotive domain. We evaluate ISO 15408 as a potential candidate for a combined safety and security approach for complementing automotive safety standard ISO 26262, and discuss their points of alignment

Kyste epidermoide intracranien

Introduction: Aim : To evaluate the value of magnetic resonance imaging (MRI) in the diagnosis of 2 cases of epidermoid cysts.Materieal and Methods: 2 cases of histopathologically proven epidermoid cysts were studied. All patients were examined with conventional MRI (T1WI, T2WI, FLAIR) and Diffusion-weighted imaging (DWI).Results: the lesions were located in the right cerebellopontine angle and the right temporal fossa. All lesions were hyperintense on T2, hypointense on T1and strikingly hyperintense on DW.Conclusion: New MR techniques such as FLAIR and DWI are most helpful tools in the specific preoperative diagnosis which is important for surgical guidance

Higher acid recovery efficiency of novel functionalized inorganic/organic composite anion exchange membranes from acidic wastewater

In this work, the synthesis of a series of the functionalized inorganic/organic composite anion exchange membranes (AEMs) was carried out by employing the varying amount of inorganic filler consist of N-(trimethoxysilylpropyl)-N,N,N-trimethylammonium chloride (TMSP-TMA+Cl-) into the quaternized poly (2, 6-dimethyl-1, 4-phenylene oxide) (QPPO) matrix for acid recovery via diffusion dialysis (DD) process. Fourier transform infrared (FTIR) spectroscopy clearly demonstrated the fabrication of the functionalized inorganic/organic composite AEMs and the subsequent membrane characteristic measurements such as ion exchange capacity (IEC), linear swelling ratio (LSR), and water uptake (WR) gave us the optimum loading condition of the filler without undesirable filler particle aggregation. These composite AEMs exhibited IEC of 2.18 to 2.29 meq/g, LSR of 13.33 to 18.52%, and WR of 46.11 to 81.66% with sufficient thermal, chemical, and mechanical stability. The diffusion dialysis (DD) test for acid recovery from artificial acid wastewater of HCl/FeCl2 showed high acid DD coefficient (UH +) (0.022 to 0.025 m/h) and high separation factor (S) (139-260) compared with the commercial membrane. Furthermore, the developed AEMs was acceptably stable (weight loss < 20%) in the acid wastewater at 60 C as an accelerated severe condition for 2 weeks. These results clearly indicated that the developed AEMs have sufficient potential for acid recovery application by DD process.Scopu

Polymorphic variants of SCN1A and EPHX1 influence plasma carbamazepine concentration, metabolism and pharmacoresistance in a population of Kosovar Albanian epileptic patients

Aim The present study aimed to evaluate the effects of gene variants in key genes influencing pharmacokinetic and pharmacodynamic of carbamazepine (CBZ) on the response in patients with epilepsy. Materials & Methods Five SNPs in two candidate genes influencing CBZ transport and metabolism, namely ABCB1 or EPHX1, and CBZ response SCN1A (sodium channel) were genotyped in 145 epileptic patients treated with CBZ as monotherapy and 100 age and sex matched healthy controls. Plasma concentrations of CBZ, carbamazepine-10,11-epoxide (CBZE) and carbamazepine-10,11-trans dihydrodiol (CBZD) were determined by HPLC-UV-DAD and adjusted for CBZ dosage/kg of body weight. Results The presence of the SCN1A IVS5-91G>A variant allele is associated with increased epilepsy susceptibility. Furthermore, carriers of the SCN1A IVS5-91G>A variant or of EPHX1 c.337T>C variant presented significantly lower levels of plasma CBZ compared to carriers of the common alleles (0.71±0.28 vs 1.11±0.69 μg/mL per mg/Kg for SCN1A IVS5-91 AA vs GG and 0.76±0.16 vs 0.94±0.49 μg/mL per mg/Kg for EPHX1 c.337 CC vs TT; PG showed a reduced microsomal epoxide hydrolase activity as reflected by a significantly decreased ratio of CBZD to CBZ (0.13±0.08 to 0.26±0.17, pT SNP and SCN1A 3148A>G variants were not associated with significant changes in CBZ pharmacokinetic. Patients resistant to CBZ treatment showed increased dosage of CBZ (657±285 vs 489±231 mg/day; P<0.001) but also increased plasma levels of CBZ (9.84±4.37 vs 7.41±3.43 μg/mL; P<0.001) compared to patients responsive to CBZ treatment. CBZ resistance was not related to any of the SNPs investigated. Conclusions The SCN1A IVS5-91G>A SNP is associated with susceptibility to epilepsy. SNPs in EPHX1 gene are influencing CBZ metabolism and disposition. CBZ plasma levels are not an indicator of resistance to the therapy